Biotech

All Articles

Former Seagen chief executive officer introduces brand new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was actually sold to Pfizer in 2015 for a tre...

Ironwood produces more purpose $1B GI drug along with new subgroup records

.On the heels of a stage 3 gain that neglected to impress investors, Ironwood Pharmaceuticals is act...

Novartis inks $150M offer for autoimmune molecular glue

.Don't cease Monte Rosa Therapies right now. The Boston-based biotech is enjoying after signing a ta...

Jade carves out director group with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of notable leadership hirings, firings as well ...

Septerna goes social along with upsized offering of $288M

.Commemorating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer called the open...

AbbVie creates Richter richer, paying out $25M to form invention treaty

.AbbVie has actually gone back to the resource of its own antipsychotic giant Vraylar seeking yet an...

GenSight enters into ultimate weeks of cash money runway as profits flow squeezes by of scope

.GenSight Biologics is actually full weeks off of lacking money. Once more. The biotech only has eno...

AZ licenses disposed of uncommon disease medicine to Monopar Therapies

.Monopar Rehabs is actually bouncing back a medication from the scrap heap of AstraZeneca's uncommon...

Arcus' brand new HIF-2a data in renal cancer hint at possible advantage over Merck's Welireg, experts claim

.Along with brand-new records out on Arcus Biosciences' speculative HIF-2a prevention, one group of ...

Roche wagers around $1B to expand Dyno gene treatment delivery treaty

.After creating a genetics therapy collaboration with Dyno Rehabs in 2020, Roche is actually back fo...